Edwards completes $4.2B sale of Critical Care to BD, adds $1.5B buyback

Edwards Lifesciences Corp

Closed all-cash sale of Critical Care to BD (NYSE: BDX) for $4.2B.
Board authorized additional $1.5B share repurchase; entered $500M accelerated repurchase.
Total $1B repurchased to date including prior $500M 10b5-1 and open-market buys.
Net proceeds to fund strategic initiatives, prior acquisitions, and share repurchases.
Company to discuss strategy and outlook at Wells Fargo Healthcare Conference on Sept 5.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.